Several hypotheses have been proposed on how chloroquine exerts its anti-cancer effect, but some preclinical studies state that it influences the TLR9/nuclear factor kappa B (NF-κB) signaling pathway, the CXCL12/CXCR4 signaling pathway and the p53 pathway. The gene discussed is NFKB1; the disease is cancer.